Dr. Vineet Talwar Takes Charge as Medical Director of RGCIRC
Dr. Vineet Talwar as its Medical Director, Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC)
RGCIRC (Rajiv Gandhi Cancer Institute & Research Centre) has announced the elevation of Dr. Vineet Talwar as its Medical Director, effective September 1, 2026. A senior medical oncologist with more than two decades of association with RGCIRC, Dr. Talwar brings extensive clinical, academic and research experience to the role.
Dr. Talwar has been serving as Director of Medical Oncology at RGCIRC and has been associated with the Department of Medical Oncology since May 2000. Over the years, he has played an important role in strengthening the institute’s medical oncology practice, while contributing to clinical research, academic training and multidisciplinary cancer care.
A DM in Medical Oncology from the Cancer Institute, Adyar, Chennai, Dr. Talwar has authored more than 140 publications in national and international peer-reviewed journals. His clinical areas of interest include genitourinary oncology, gastrointestinal oncology, hepatopancreatobiliary oncology and breast oncology. He has also been actively involved in Phase II, III and IV clinical trials and has served in several academic and institutional roles, including as an examiner for DNB Medical Oncology trainees.
His professional affiliations include the European Society for Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), Indian Society of Oncology (ISO) and Indian Cooperative Oncology Network (ICON). He is also a Fellow of the Royal College of Physicians(FRCP), Edinburgh, and has received several recognitions over the course of his career, including the Chikitsa Ratan Award and multiple academic orations.
In his new role as Medical Director, Dr. Talwar will work closely with RGCIRC’s leadership and clinical teams to further strengthen multidisciplinary cancer care, quality standards, academic programmes and research initiatives across the institute.
Speaking on his elevation, Dr. Vineet Talwar, Medical Director, RGCIRC, said, “RGCIRC has been an integral part of my professional journey for more than two decades, and its an honour to take on this larger responsibility. Oncology is evolving rapidly, and our focus must remain on bringing together clinical excellence, multidisciplinary decision-making, research and compassionate care. I look forward to working with our teams to further strengthen our clinical and organisational processes, while embracing AI and other cutting-edge technologies to enhance decision-making, improve outcomes and deliver greater value to our patients. Our endeavour will be to ensure that every patient benefits from the best possible evidence-based treatment, supported by innovation, technology and compassionate care.”
Welcoming Dr. Talwar to the new role, Dr. Dharmendra Singh Gangwar, CEO, RGCIRC, said, “Dr. Talwar has made a significant contribution to RGCIRC over the years as a clinician, academician and researcher. His deep understanding of oncology, experience within the institution and commitment to patient care make him well placed to take on the responsibility of Medical Director. We are confident that his leadership will further strengthen clinical integration, academic excellence and research across the institute.”
Dr. Talwar’s elevation comes at a time when RGCIRC continues to expand its clinical and research capabilities and deepen its focus on multidisciplinary, evidence-based oncology. His appointment reflects the institute’s emphasis on strengthening medical leadership from within while building on established expertise and institutional continuity.
Guided by its core values of Ethics, Empathy and Excellence, RGCIRC continues to advance comprehensive cancer care, research and medical education while working towards better outcomes and quality of life for patients across India.
Got a story that Healthcare Executive should dig into? Shoot it over to arunima.rajan@hosmac.com—no PR fluff, just solid leads.